(Q48000638)

7 February 2018

title

Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo (English)

1 reference

7 February 2018

10

M M Le Beau

1 reference

7 February 2018

author name string

Z Qian

1

1 reference

7 February 2018

L Mao

2

1 reference

7 February 2018

A A Fernald

3

1 reference

7 February 2018

H Yu

4

1 reference

7 February 2018

R Luo

5

1 reference

7 February 2018

Y Jiang

6

1 reference

7 February 2018

J Anastasi

7

1 reference

7 February 2018

P J Valk

8

1 reference

7 February 2018

R Delwel

9

1 reference

7 February 2018

publication date

16 April 2009

1 reference

7 February 2018

published in

Leukemia

1 reference

7 February 2018

volume

23

1 reference

7 February 2018

issue

9

1 reference

7 February 2018

page(s)

1650-1657

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/leu.2009.78

exact match

0 references

cites work

Insights into leukemogenesis from therapy-related leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

The LIM domain: regulation by association

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

The multifunctional roles of the four-and-a-half-LIM only protein FHL2.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

FHL2 (SLIM3) is not essential for cardiac development and function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

A critical role for Apc in hematopoietic stem and progenitor cell survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

The LIM-only protein FHL2 is a negative regulator of E4F1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Identification of the LIM protein FHL2 as a coactivator of beta-catenin

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Induction of apoptosis in fibroblasts by c-myc protein

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.78

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.78

1 reference

7 February 2018

1 reference

7 February 2018